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Abstract  In  this  study  we  developed  an  indirect  ELISA  to  detect  antibodies  against  Minute  Virus
of Mice  (MVM)  using  an  antigen  produced  from  BHK-21  cells  infected  with  a  prototype  strain
of the  virus.  The  optimal  antigen  concentration  and  serum  dilutions  were  established.  In  order
to analyze  variability  in the  laboratory,  reproducibility  and  repeatability  within  and  between
plates  were  determined.  Then,  a  panel  of  460  sera  from  conventional  facilities  and  previously
classiﬁed as  positive  or  negative  by  the  indirect  ﬂuorescent  antibody  assay  was  analyzed.  The
cutoff  value  was  determined  by  a  receiver  operating  characteristic  (ROC)  curve.  The  results  of
the indirect  ELISA  were  compared  with  those  of  the  indirect  ﬂuorescent  antibody  assay.  The
ELISA assay  showed  100%  sensitivity  and  99%  speciﬁcity.  ELISA  is  a  useful  tool  to  be developed  in
standard virology  laboratories  and  can  be used  for  screening  animals  faster  than  the  traditional
indirect  ﬂuorescent  antibody  assay.
©  2017  Asociacio´n Argentina  de Microbiolog´ıa.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).∗ Corresponding author.
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ELISA  indirecto  (iELISA)  para  la  detección  de rutina  de anticuerpos  contra  el  virus
diminuto  del ratón  (MVM)  en  colonias  de  ratones
Resumen  Se  desarrolló  un  ELISA  indirecto  para  detectar  anticuerpos  contra  el  virus  diminuto
del ratón  (Mice  minute  virus  [MVM]),  utilizando  un  antígeno  producido  a  partir  de  células  BHK-21
infectadas  con  la  cepa  prototipo  del  virus.  Se  establecieron  las  diluciones  óptimas  de  antígeno
y el  suero  a  utilizar.  Para  analizar  la  variabilidad  en  el  laboratorio,  se  determinaron  la  repro-
ducibilidad  y  la  repetibilidad  dentro  de una  placa  y  entre  placas.  Luego  se  analizaron  460  sueros
provenientes  de  bioterios  convencionales  y  clasiﬁcados  previamente  como  positivos  o  negativos
por inmunoﬂuorescencia  indirecta.  El  valor  de corte  se  determinó  mediante  una  curva  ROC.  Los
resultados  se  compararon  con  los  obtenidos  con  la  prueba  de inmunoﬂuorescencia  indirecta.
El ELISA  mostró  100%  de sensibilidad  y  un  99%  de  especiﬁcidad.  Esta  técnica  demostró  ser  una
herramienta  útil  para  desarrollar  en  laboratorios  de  virología  estándar  y  puede  utilizarse  como
prueba tamiz  para  seleccionar  animales  de manera  más rápida  que  con  la  tradicional  prueba
de inmunoﬂuorescencia  indirecta.
© 2017  Asociacio´n  Argentina  de Microbiolog´ıa.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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TThe  presence  of infectious  agents  represents  a serious
problem  in laboratory  animal  colonies.  Some  of  these agents
can  induce  clinical  signs  and  subclinical  or  asymptomatic
infections.  Minute  Virus of  Mice  (MVM)  and  Mouse  Parvovirus
(MPV)  are  two  highly  prevalent  infectious  agents  in mice
colonies2.  MVM  is  a self-limiting  virus  and  antibodies  are
detected  up  to  4  weeks  after  infection  in immunocompe-
tent  animals6;  however,  experimental  infection  will  result
in  severe  damage  to  multiple  organs  mainly  in  developing
fetuses  and neonates9.  Infection  with  an immunosuppress-
ive  strain  of MVM  can  result  either  in  runting  or  in  death,
depending  on  the virus  dose  and  mouse  strain3,5.  Clinical
disease  or  histological  lesions  have not  been  observed  in
naturally  or  experimentally  infected  mice  with  MPV;  how-
ever,  this  parvovirus  is  considered  an important  pathogen
since  it produces  T-lymphocyte  dysfunction,  alters  graft  pat-
terns  and  causes  tumor  rejection3.  MPV  persists  for  9  weeks
in  immunocompetent  murine  tissues  and  seems  to  occur
in  a  low prevalence  within  mouse  colonies9.  MVM  and  MPV
can  modify  physiological  parameters  and produce  signiﬁcant
changes  in experimental  results8,10. They  can directly  reduce
the  tumor  growth  rate,  prevent  its  development  or  alter
the  modulation  of the  immune  response  against  tumoral
cells5. In  addition,  in  immunological  studies,  MVM  and  MPV
can  interfere  with  the  modulation  of  lymphocytes  and  the
generation  of  ascites.  These  viruses  interfere  in infectious
diseases  and cell biological  studies,  and  can  also  alter  pat-
terns  of  rejection  of  skin  allografts10.  Since  MVM  and  MPV
are  resistant  to inactivation  there  is  a  great  risk  of  trans-
mission  by  feces,  urine  and contaminated  supplies  (cages,
litters,  beds, food,  etc.).  Like  all  parvoviruses,  MVM  and MPV
replicate  in proliferating  cells.  For  all  these  reasons,  the
development  of  sensitive  detection  techniques  may  allow
to  know  how  efﬁcient  barrier  systems  in mice  colonies  are,
and  it may  also  help  to  obtain  the prevalence  data  of  these
viruses  to  know  the  magnitude  of  the infection  in order
to  implement  the appropriate  control  measures.  The  ﬁrst
isolation  of  MVM  was  obtained  from  a  mouse  adenovirus
stock,  which  was  then  grown  in a mouse  embryo  culture,
n
n
flaque  puriﬁed  in mouse  ﬁbroblasts  without  forced  adap-
ive  passages  and  renamed  MVM  prototype  (MVMp)13. Other
hree  MVM  strains  have been  described:  MVMi  (an  immu-
osuppressive  variant  isolated  from  transplantable  mouse
ymphoma),  MVMc  (a  cutter  strain  isolated  as  a contami-
ant  of BHK-21  cells)  and  MVMm  (a Missouri  strain  isolated
rom  naturally  infected  B-cell-deﬁcient  mice).  MVMp  and
VMi  are 97% homologous  at the genomic  level  and  serolog-
cally  indistinguishable  and the most  studied  strains.  Recent
tudies  indicate  that  several  factors,  including  age,  viral
ose,  mouse  strain  and for  some  strains  even  gender,  inﬂu-
nce  the  serological  response4.  Five strains  of  MPV  (MPV-1,
,  3, 4  and  5) have been described  and  several  genotypic
ariants  (MPV-1a,  1b,  1c,  1d,  1e  and  1UT)  of  MPV1 were
ecognized.  MPV-1  is  most  closely  related  genetically  to
VM  strains5.  MVM  and  MPV  are composed  of  two  structural
roteins,  capsid  proteins  VP2  and  VP1,  and  of  two  non-
tructural-proteins,  NS1  and  NS2.  VP1  and VP2  vary between
oth  viruses  and  determine  the  serogroup  for  a  particular
train  while  NS1  and  NS2  are well  conserved  between  these
iruses.  For example,  between  NS1  of  MVM  and  MPV  there
s  more  than  90%  identity6.  Currently,  MVM  and  MPV  are
onitored  by  serological  detection  of  antiviral  antibodies  in
he  host6.  The  hemagglutination  inhibition  test  was  the  ﬁrst
echnique  used  for antibody  detection  but  requires  large
mounts  of  viral  antigen.  More  recently  the two  most  used
erological  techniques  are the  indirect  ﬂuorescent  antibody
ssay  (IFA) and  the  enzyme-linked  immunosorbent  assay
ELISA)1.
Antigens  used for IFA  and  some  antigens  for ELISA  are
roduced  with  MVM-infected  cells  and  contain  NS proteins
s  well  as  VP.  For  that  reason it is  difﬁcult  to  distinguish
hether  mice  are infected  with  MVM  or  MPV.  Antigens  used
or  conventional  ELISA  and produced  with  MVM  virions  mainly
ontain  VP  and  also  include  small amounts  of  NS  proteins.
he  IFA  is  a  speciﬁc  and  useful  method  to  analyze  a  small
umber  of  serum  samples.  ELISA  is  a  good  screening  tech-
ique  and  its  use  could  be  systematized  as  a  routine  control
or  a  higher  number  of samples6.
2 J.M.  Laborde  et  al.
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Figure  1  SDS--PAGE  analysis  of  ELISA  antigen.  Lane  M:  molec-
ular weight  marker  proteins  with  the  sizes  indicated.  Lane  1:
1:100 dilutions  of  ﬁnal  antigen  for  ELISA.  Arrows  indicate  bands
of viral  proteins  and  molecular  weight  in  brackets:  VP1/NS1
(83--85  kDa),  VP2  (64  kDa)  and  NS2  (25  kDa).  Lane  2: supernatant
of 36  h of  culture  of  BHK-21  cells  infected  simultaneously  with
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In  this  work  we  describe  the development  of  an indirect
LISA  (iELISA)  that  would be  useful  for MVM  screening  in mice
olonies,  using  an antigen  of  easy  production  from  BHK-21
ell  cultures  infected  with  the  virus.
For  antigen  preparation,  MVMp  (ATCC® VR-1346)  was  pro-
ided  by  the  Multidisciplinary  Center  for Biological  Research
n  Laboratory  Animal  Science  (CEMIB,  University  of  Campi-
as  of  Brazil).  The  strain  was  propagated  on  baby  hamster’s
idney  (BHK-21)  cells  (Argentine  Cell  Bank  Association,
rgentina),  grown  in Minimum  Essential  Medium  (MEM)
Gibco,  Invitrogen,  USA)  supplemented  with  2  mM  glutamine
Gibco,  Invitrogen,  USA),  100 IU/ml  penicillin,  100 mg/ml
treptomycin  (Ritchet,  Buenos  Aires,  Argentina),  100 IU/ml
ystatin  (Parafarm,  Buenos  Aires, Argentina)  and 10%  fetal
alf  serum,  which  was  reduced  to  2% for  maintenance  of
ells.  BHK-21  cells  preserved  in liquid  nitrogen  were  thawed
nd  used for  no  more  than  three  passages.  Cells  were
arvested  with  trypsin  (0.25%  (w/v))--Ethylene  Diamine
etraacetic  Acid--EDTA  (0.2%  (w/v))  (Sigma--Aldrich,  USA).
hen,  individual  T-75  ﬂasks of  BHK-21  cells  (3.75  × 106 cells
n  20  ml of growth  MEM)  were  infected  (‘‘Inf’’)  with  300 ml of
iral  stock  solution  (hemagglutination  (HA)  titer  of  1:128)  at
hree  different  times:  0  h  (‘‘Inf  0’’), 12  h  (‘‘Inf  12’’)  and  24  h
‘‘Inf  24’’)  of  development  of  the  cell  monolayer.  In  ‘‘Inf  0’’
ells,  a cytopathic  effect  was  observed  at  24  h  post-infection
nd  the  supernatant  that was  collected  at 36  h  of  culture  was
easured  by  HA.  In  the  other  two  experiments  (‘‘Inf  12’’  and
‘Inf  24’’)  a  cytopathic  effect  was  not  observed  and  the  HA
est  was  negative  from  culture  supernatants  developed  daily
ntil  5  days  post-infection.  The  experiments  were  repeated
hree  times  in order  to  conﬁrm  the results.  Five hundred  ml
f  infectious  supernatant  (HA  titer  of 1:2048)  of  ‘‘Inf  0’’  cells
ere  used  for  antigen  preparation.  Cell  debris  was  clariﬁed
y  centrifugation  at 4000  × g for  30  min  and  then  the  viral
articles  were  concentrated  by  centrifugation  at 25  000  ×  g
or  5  h  at 4 ◦C.  The  pellet  was  suspended  in 1 ml of phosphate
uffered  saline  (PBS)  before  being  layered  on  a discontin-
ous  20--60%  (w/w)  sucrose  gradient  and centrifuged  as  a
oncentration  step.  The  visible  band  was  collected  (∼2  ml),
iluted  in the same  volume  of  PBS,  concentrated  by  cen-
rifugation  as  previously  described,  and then  the pellet
as  diluted  in 500  ml of  PBS  in  order  to  determine  protein
oncentration  (Fluorometer  Qubit  2.0,  Invitrogen,  Life  Tech-
ology,  Japan).  An  assay  of  SDS--PAGE  was  developed  with
rst  infectious  supernatant  and  with  the ﬁnal  antigen,  con-
rming  the presence  of  bands  of  molecular  weight  similar
o  viral  proteins  in the  antigen  (Fig.  1). The  optimal  antigen
ilution  was  established  by  a  checkerboard  titration  with
ositive  and  negative  reference  serum  provided  by  CEMIB,
niversity  of  Campinas  of Brazil.  The  antigen  was  coated  in
6-well  ELISA  plates  (NUNC  Maxisorp,  Hamburg,  Germany)
anging  in concentration  from  6.24  to  0.003  mg/ml  in a  ﬁnal
olume  of  100 ml/well  of  50  mM  in carbonate/bicarbonate
uffer  (pH  9.6).  The  plates  were  incubated  overnight  at 4 ◦C.
fter  removing  excess  unbound  antigen,  100  ml of  blocking
olution  (PBS  --  0.1%  bovine  serum  albumin)  were  added  to
ach  well  and  incubated  for  1 h  at 37 ◦C. Plates  were  washed
ve  times  with  PBS plus  0.5%  Tween-20  (PBST).  Positive  and
egative  reference  serum  samples  were  diluted  serially  from
:5  to 1:640  (50  ml/well) in PBST  plus  5% skim  milk  powder
nd  incubated  for  1 h at  laboratory  under  proper  controlled
onditions  (22--24 ◦C).  Then,  plates  were  washed  ﬁve  times
a
w
a
in MVM  prototype  strain.  A broad  band  of  66  kDa  corresponding
o bovine  serum  albumin  can  be observed.
ith  PBST.  Anti-mouse  IgG  peroxidase  (Sigma--Aldrich,  St
ouis,  MO, USA)  was  used  as  secondary  antibody  accord-
ng to  the manufacturer’s  instructions  and  incubated  for
 h  in the  laboratory  under  proper  controlled  conditions
22--24 ◦C).  ABTS  (30  mg)  substrate  (2,20-azino-di-[3-ethyl-
enzothiazoline-6-sulphonic  acid])  (Sigma--Aldrich,  St Louis,
O,  USA)  was  diluted  in  50  ml  of  citrate  acid  buffer  (0.1  M)
lus  50  ml of  sodium  phosphate  (0.2 M)  and 10 ml of  30%
2O2.  Optical  density  (OD)  values  were  determined  using
n  ELISA  reader  (Thermo  Scientiﬁc  Multiskan  FC,  Vantaa,
inland)  at  405  nm  at room  temperature  after  30,  40  and
0  min  of  incubation.  Dilutions  of  antigen  1:1600  (195  ng/ml)
nd  1:3200  (97.5  ng/ml)  were  selected  since  they  gave  the
aximum  difference  of  OD  between  positive  and  negative
eference  serum  samples.  Optimal  dilution  of  serum  was
btained  by  analysis  of  these  two  dilutions  of  antigen  with
-fold  serial  dilutions  of an initial  1:5  dilution  of  positive
nd  negative  reference  serum  and  four  sera (two negative
nd  two  positive)  from  conventional  facilities  and classiﬁed
y  IFA. In  order  to  investigate  variability  in the  labora-
ory,  reproducibility  and repeatability  within  and  between
LISA  plates  were  determined.  To  this  purpose,  four  trials
n  different  days  with  forty  four  mice  sera  from  conven-
ional  facilities  and two  MPV  positive  control  sera  provided
y  CEMIB,  University  of  Campinas  of  Brazil,  were analyzed
wice  each by  duplicate  using  a working  dilution  previously
etermined12.  These  sera  were  previously  classiﬁed  as  pos-
tive  or  negative  using the IFA  as  gold  standard  test. The
ispersion  of  the  mean  of  OD  values  of each serum  was
nalyzed  by  a  coefﬁcient  of variation  (CV) with  20%  tol-
rance.  The  concordance  correlation  coefﬁcient  (CCC)  was
sed  to  evaluate  repeatability.  All the analysis  was  car-
ied  out  using  the statistical  package  Stata11
®
. The  CV  for
ll  plates  ranged  between  4.84%  and  17.92%.  Repeatability
ithin  and  between  plates  was  0.998  (CI 95%  0.997--0.998)
nd  0.996  (CI 95%  0.993--0.998),  respectively  (Fig.  2)  indicat-
ng  acceptable  values  according  to  the standard  empirical
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Figure  2  Results  of  four  trials  with  forty-six  sera  analyzed  on
different  days.  Repeatability  within  plates  (up)  and between
Table  1 Comparison  of  results  obtained  from  460  mice
sera  of  conventional  facilities  analyzed  by  the  indirect  ﬂu-
orescent  antibody  test  (IFA)  and  the  indirect  enzyme-linked
immunosorbent  assay  (iELISA)*
Test iELISA
(+) (−)  Total
IFA  (+) 77  0  77
IFA (iELISA) 3  380 383
Total 80  380 460
* (+), positive; (−), negative.
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the  detection  of  speciﬁc  antibodies  against  MVM  or  MPV  by
using  recombinant  VP  and  NS proteins.  Some  authors  high-
light  the fact  that  ELISA  with  recombinant  NS protein  lacks
sensitivity  for serodiagnosis  and for  detection  of  infection.
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Figure  3  Receiver  operating  characteristic  (ROC)  curve
obtained  from  panel  of  460 mice  sera  of  conventional  facili-plates (down)  was  analyzed  by  concordance  correlation  coefﬁ-
cient.
criteria  suggested  by  Jacobson  (1998)4. Finally,  the 1:3200
dilution  of antigen  (97.5  ng/ml  of  total  proteins)  was  used
considering  that  the  same  serum  showed  higher  OD  than
with  1/1600  dilution.  A panel of  460  sera  from  conven-
tional  facilities  of  Argentina  and classiﬁed  as  positive  or
negative  by  the  IFA  was  analyzed  in a previously  deter-
mined  1:10  dilution.  The  blocking  and  washing  solutions
were  the same  as  those  already  described.  An  incubation
time  with  substrate  of  40  min  was  selected  for all  analysis.
The  results  were  normalized  by  using  the following  formula:
OD  = OD  −  Nt/Pst  −  Nt,  where  OD  is  the  mean  OD  value  of
each  simple  serum  determined  by  duplicated  wells,  and  Pst
and  Nt are the  mean  OD  values  of  the  positive  and  nega-
tive  control  serum  samples,  respectively11.  The  cutoff  value
of  0.3  was  determined  by  the ROC  curve.  The  results  of
the  ELISA  assay  were  compared  with  those  of the IFA  as
the  gold  standard  technique.  The  iELISA  showed  100%  sen-
sitivity  and  99%  speciﬁcity  (Table  1,  Fig.  3). Three  negative
sera  by  the IFA  were  detected  as  positive  by  ELISA.  As  the
reading  of  OD  values  for  each  serum  has  been  statistically
corroborated  by  CCC  and CV  we  think  that  those  results
were  indeed due  to the conjunction  of  possible  variations
in  both  techniques.  A percentage  of  18.75  and  18.13% of  the
analyzed  sera  were  found  to be  positive  by  iELISA  and  IFA,
respectively.MVM  and  MPV  are  the  most  prevalent  viruses  in mouse
colonies;  therefore,  routine  screening  is  always  needed.
The  IFA  was  used  for  several  years  in many  countries  with
t
t
dSensitivity 100%, speciﬁcity 99%.
Kappa (95% CI) =  0.97 (0.951--1.000).
atisfactory  results;  however,  it  is  a  laborious  technique  on
 high  number  of samples.  In  this  work  we  developed  an
ELISA  with  an antigen  yielder  and  easy  to  obtain.  Growth
f  MPV  in cell  cultures  is  difﬁcult;  however  MVM  can  grow
n  speciﬁc  cell lines6. We  used  a MVMp  strain  and  BHK-21
ells  for  antigen  production  in  contrast  with  other  antigens
repared  from  murine-infected  cell  cultures  (L929),  since
HK-21  showed  a fast  growing  cell  line  in the  ﬁrst  12  h. Fur-
hermore,  the method  to  obtain  the  virions  was  simple,  and
igh  speed  centrifugation  for  puriﬁcation  was  not  neces-
ary.  The  best antigen  was  achieved  when  trypsinized  cell
ultures  were  seeded  in bottles  and  infected  with  MVMp
imultaneously,  possibly  since  most of the  cells  were  in the
-phase  of  cell  cycle  interphase.  In the  other  two  experi-
ents  the lack  or  decrease  of  cells  in the S-phase  did  not
ause  productive  viral  replication  and  for that  reason  the
ytopathic  effect  was  not  observed  and  HA activity  was  not
etected  from  the culture  supernatants.  In  the last  years,
lternative  ELISA  were  developed  in several  laboratories  fories and  analyzed  by  the  indirect  ﬂuorescent  antibody  test  and
he indirect  enzyme-linked  immunosorbent  assay  for  serologic
etection  of  Minute  Virus  of  Mice.
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herefore,  they  proposed  recombinant  VP2  and NS1  proteins
f  MVM  with  VP2  protein  of MPV  combinations3,6,8. The  use
f  baculovirus-expressed  recombinant  proteins  for  antigen
roduction  is  not  always  reproducible  in standard  virology
iagnostic  laboratories;  this  is  the  reason  why our  ﬁrst  step
o  develop  this  iELISA  was  to obtain  an antigen  of easy  pro-
uction  using infected  cell  cultures.  It  could  be  obtained  in
ess  than  72  h using basic  virology  methods  and  an infected
ell  line.  The  iELISA  test  developed  here  has  shown  to  be
peciﬁc,  making  it  possible  to  rapidly  test  large number  of
amples  to  detect  MVM  antibodies  in murine  colonies.  One
reliminary  assay  analyzing  two  MPV  control  positive  sera
y  IFA  that were  also  detected  positive  by  this  iELISA  could
ndicate  cross-reactivity.  This  ﬁnding  may  be due  to the fact
hat  although  conventional  antigens  contain  high  amounts
f  VP,  they  also  include  small  amounts  of  NS proteins  that
ould  be  responsible  for the  cross-reaction6.  To  conﬁrm  this
rst  result,  a higher  number  of sera  should  be analyzed
omparatively  with  more  speciﬁc  antigens  for  MPV7 and our
ELISA.  The  serological  results  obtained  are  consistent  with
hose  previously  reported7 and,  are probably  the result  of
he  lack  of  implementation  of  barrier  systems  in most  con-
entional  facilities  of  Argentina.  In  contrast,  in the  United
tates  of  America  and  some  European  countries,  the  per-
entage  of  positive  animals  (1--3  and  2--8%,  respectively),
s  lower  surely  because  most institutions  produce  rodents
ree  of  speciﬁc  pathogens5,11.  In  addition,  other  authors  also
uggested  that  seroprevalence  is  variable  among  different
urine  strains3,4,6.  Parvoviruses  are  one of  the most com-
on  laboratory  rodent  infectious  agents.  Serological  results
ndicate  that  MVM  is  circulating  in  conventional  facilities  of
rgentina.  With  this  iELISA  the  surveillance  of  mice  colonies
n  Argentina  could  be  increased  to  know  their  real health
tatus.  In addition,  it will  contribute  to  prevent  the transmis-
ion  among  animal  facilities  and to  minimize  its  interference
n  research  studies.  Serological  techniques  remain  the  most
ffective  methods  of  screening  mouse  populations  for  viral
nfections.  Several  factors  contribute  to  the  problem  of  con-
rolling  MVM  infections,  including  the existence  of different
irus  strains  as  well  as  factors  associated  with  the  host
e.g.  genetic  background,  age,  gender)4.  MVM  infections
ontinue  to  be  a problem  in  laboratory  mice  facilities;  there-
ore,  sensitive  and  speciﬁc  techniques  must  be  continuously
eveloped.
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